HSBP1 and neoplasm: While there was no significant difference in tumor mutation burden (TMB) between the groups (Fig. 5B), the expression levels of HSBP1 were higher in samples with elevated TMB, whereas GCLC expression did not vary significantly with changes in TMB (Fig. 5C, D).